Position in PRGO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$238,824
+$226,914 QoQ
Shares Held
22,986
+1972.7% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#175
of 334 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $14,581,452 across 56 Drug Manufacturers - Specialty & Generic names. PRGO ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
24,261 | $4,088,948 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
6,216 | $3,368,015 | |
| 3 | VTRS |
Viatris Inc
|
83,877 | $1,331,966 | |
| 4 | HLN |
Haleon plc
|
81,966 | $764,742 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
21,768 | $737,499 | |
| 6 | ZTS |
Zoetis Inc.
|
9,047 | $650,117 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
39,210 | $628,536 | |
| 8 | IRWD |
Ironwood Pharmaceuticals Inc
|
126,966 | $534,526 |
All Filings in PRGO
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,824 | 22,986 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $11,910 | 1,109 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,280 | 92 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $64,555 | 2,416 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $98,980 | 3,530 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,895 | 1,085 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $86,899 | 3,313 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $82,740 | 3,222 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $111,537 | 3,465 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $101,495 | 3,154 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $74,410 | 2,329 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $83,143 | 2,449 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $71,022 | 1,980 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $58,191 | 1,707 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $58,589 | 1,643 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $61,544 | 1,517 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $58,106 | 1,512 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $48,897 | 1,257 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $70,379 | 1,487 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $67,720 | 1,477 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $56,391 | 1,261 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $52,980 | 1,154 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $28,906 | 523 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $25,151 | 523 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||